Under review

The ACCC has launched a review into the proposed merger of Arrow and Apotex Early last month, Arrow Pharmaceuticals and Apotex announced a proposed merger of their Australian and New Zealand generic pharmaceutical and OTC operations. In a statement, the two companies said the move was still subject to several conditions, including ACCC approval and